Operator
Good evening, ladies and gentlemen, and welcome to the First Quarter of 2021 Earnings Conference Call for Tactile Medical. [Operator Instructions] At the end of the Company s prepared remarks, we will conduct a question-and-answer session.
Please note that this conference call is being recorded and will be available on the Company s website for replay shortly. Before we begin, I would like to remind everyone that our remarks and responses to your questions today may contain forward-looking statements that are based on the current expectations of management and involve inherent risks and uncertainties that could cause actual results to differ materially from those indicated, including those identified in the risk factors section of our Annual Report on Form 10-K, as well as our most recent 10-Q filing, filed today with the Securities and Exchange Commission. Such factors may be updated from time to time in our filings with the SEC, which are available on our website.
Share:
ResearchAndMarkets.com s offering.
This report delivers an in-depth understanding of the CVU, historical and forecasted epidemiology as well as the CVU market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
The CVU market report provides current treatment practices, emerging drugs, and market share of the individual therapies, current and forecasted 7MM CVU market size from 2017 to 2030. The report also covers current CVU treatment practice/algorithm, market drivers, market barriers and unmet medical needs to curate the best of the opportunities and assesses the underlying potential of the market.
Scope of the Report
Vetex Medical Announces Positive One-Year Outcomes for ReVene Thrombectomy Catheter apnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from apnews.com Daily Mail and Mail on Sunday newspapers.
Vetex Medical Ltd.: Vetex Medical Announces Positive One-Year Outcomes for ReVene Thrombectomy Catheter
Study Met Primary Endpoint; 100 Percent of Patients Studied Through 12 Months Experienced Improved Symptoms and Quality of Life Vetex Medical Ltd. today announced positive one-year results from a European clinical study of patients with iliofemoral vein thrombus that demonstrated that the ReVene Thrombectomy Catheter significantly improved their symptoms and quality of life, while reducing their leg swelling. Results were presented today at VENOUS 2021, the annual meeting of the American Venous Forum, by principal investigator Stephen A. Black, MD, Consultant Vascular Surgeon, Guy s and St Thomas Hospital NHS Foundation Trust and Professor of Venous Surgery, Kings College Hospital, London.
Announcing Prominent Vascular Surgeon Joins Advanced Dermatology PC
Share Article
Dr. John Gallagher
Integration of these two medical practices ensures patients access to the most effective, pain-free measures for relieving the discomfort of venous insufficiency, while providing them with the best possible cosmetic outcomes. MINEOLA, N.Y. (PRWEB) January 25, 2021 Prominent vascular surgeon John F. Gallagher MD, FACS, RVT, RPVI of Island Vein Specialists has joined the team at New York- and New Jersey-based Advanced Dermatology, PC. The appointment creates a revolutionary synergy between two practices known for their innovation in treating chronic venous insufficiency and eliminating the unsightly varicose and spider veins that characterize the disorder.